Historical record - last NADAC publication: 7/22/2020
Product Information
IMATINIB MESYLATE 100 MG TAB is a generic product labeled by Ascend Laboratories, LLC, priced at $3.1369 per EA under NDC 67877063390. Its NADAC has been published 87 times since Apr 10, 2019.
The High Outlier badge above means this manufacturer's average price in the imatinib mesylate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
100 mg/1
Manufacturer
Ascend Laboratories, LLCNDC
67877063390
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
7/22/2020
Active Ingredients
IMATINIB MESYLATEApproval Type
Generic (ANDA)
FDA Application
ANDA208302On Market Since
2/1/2019
Pharmacological Classes
Price Statistics
The NADAC for IMATINIB MESYLATE 100 MG TAB has been published 87 times since Apr 10, 2019, and over the history we have for it it has declined 36.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.1369 per EA |
|---|---|
| All-time high | $4.9463 (Feb 12, 2020) |
| All-time low | $2.0686 (Feb 19, 2020) |
| Median price | $4.9463 |
| Average price | $3.8027 |
| Largest weekly change | -58.2% (Feb 19, 2020) |
| Weeks tracked | 87 |
| Tracking since | Apr 10, 2019 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 84% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of IMATINIB MESYLATE 100 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for IMATINIB MESYLATE 100 MG TAB, manufactured by Ascend Laboratories, LLC, is $3.1369 per EA (NDC 67877063390), effective Dec 2, 2020.
How has the price of IMATINIB MESYLATE 100 MG TAB changed over time?
Over the history we have for it, the NADAC for IMATINIB MESYLATE 100 MG TAB has declined 36.6%. It has been tracked across 87 weekly CMS publications since Apr 10, 2019.
What are the highest and lowest recorded NADAC prices for IMATINIB MESYLATE 100 MG TAB?
Since Apr 10, 2019, the NADAC for IMATINIB MESYLATE 100 MG TAB has ranged from a low of $2.0686 (Feb 19, 2020) to a high of $4.9463 (Feb 12, 2020), with a median of $4.9463 per EA.
Are there cheaper alternatives to IMATINIB MESYLATE 100 MG TAB?
Yes. 6 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, IMATINIB MESYLATE 100 MG TAB, is $0.4912 per EA — about 84% below IMATINIB MESYLATE 100 MG TAB.
Who manufactures IMATINIB MESYLATE 100 MG TAB?
IMATINIB MESYLATE 100 MG TAB (NDC 67877063390) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification